In line with its potential role in DCIS, data from publicly available invasive breast carcinoma repositories showed that while high RNA expression of β6 in the bulk tumour was associated with higher levels of EP300, MMP13 expression was also significantly increased in high EP300 expressing patients (Supplementary Fig. 5d). This evidence concerns the gene EP300 and invasive breast carcinoma.